Follow us on
  • Linkedin
  • Twitter
  • Facebook
  • Google+


  • 2012 03 08

    Life Sciences Baltics 2012 Forum was Presented in Houston

    On March 7, 2012, during the official visit of Mr. Gintaras Steponavicius, Minister of Education & Science, Republic of Lithuania to the Trevisio Medical Centre, Houston (USA), International Conference Life Sciences Baltics 2012 had been presented. At this high-level meeting the benefits for the US researchers and companies via cooperation with Lithuanian most advanced valleys had been discussed.

  • 2012 03 04

    “Enterprise Estonia” has become a partner Agency of Life Sciences Baltics 2012

    “Enterprise Lithuania”, the main organizer of the event, keeps a close contact with “Enterprise Estonia” and works togeather to ensure the best results of cooperation in organizing this state-of-art International Conference. To find more information about our new partner, please visit

  • 2012 01 30

    Nobel Prize winner Professor Ada E. Yonath (Israel) will open the Plenary Session

    Professor Ada E. Yonath (Israel), Nobel Prize winner in Chemistry (2009) will open the Plenary Session at the Life Sciences Baltics 2012 forum. Ms Ada E. Yonath was born in 1939, in Jerusalem. In 1962 she graduated from the Hebrew University of Jerusalem with the Bachelor's degree in chemistry. She received her Master's degree in biochemistry in 1964 and in 1968 she earned the PhD. in X-Ray crystallography at the Weizmann Institute of Science. Currently Ms Ada E. Yonath is the director of Helen and Milton A. KimmelmanCenter for Biomolecular Structure and Assembly of the Weizmann Institute of Science. She is best known for her work in the field of the structure of the ribosome. Professor Ada E. Yonath is a member of the United States National Academy of Sciences; the American Academy of Arts and Sciences; the Israel Academy of Sciences and Humanities; the European Academy of Sciences and Art and the European Molecular Biology Organization.

  • 2012 01 24

    Mr.Andrius Kubilius, Prime Minister of the Republic of Lithuania, is the official patron of the event

    Mr. Andrius Kubilius, Prime Minister of the Republic of Lithuania, is the official patron of Life Sciences Baltics 2012. One of the key priorities of the Lithuanian Government is to encourage the successful development of the life sciences sector into the Northern Europe’s Life Sciences Hub.

  • 2012 01 15

    Israeli company Kaleidoscope charged with the responsibility of organizing the event

    Kaleidoscope, Israel based highly professional planning and events’ organizing company with global experience is charged with the responsibility for the development of the forum programme, for attracting prominent keynote speakers, and for ensuring that the Life Sciences Baltics 2012 is a truly successful and memorable international event.

  • 2012 01 14

    Life Sciences Baltics 2012 Ambassadors‘ Club is gaining momentums

    Life Sciences Baltics 2012 has already united 70 Event Ambassadors from Lithuaniawho will join their efforts in further developing the cooperation between science and business. The group of Event Ambassadors includes leading experts in biotechnology, well-known figures from business, science and academic sectors. The Event Ambassadors from Latvia and Estonia will also join this group shortly to make their tribute to the event.

  • 2011 08 31

    Life Sciences Baltics 2012 to take place in Vilnius, Lithuania

    Life Sciences Baltics 2012, to be held in Vilnius, Lithuania on September 12-14, 2012 is to become the biggest international life sciences forum in this rapidly growing part of the EU. Up to 400 attendees are expected - leading experts within the field of biotechnology science and business from all over the world. The forum will shed light on the significant achievements and great potential of the Baltic States in the area of life sciences and will promote the exciting opportunities for scientific and business cooperation development. The delegates will include representatives of the leading biotechnology, pharmaceutical companies, venture capital funds, biomedicine scientists, experts, consultants, investors, corporate executives and the Baltic States’ expatriates active within the sector.